Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended on December 31, 2024.